2.7437

0.72% -0.0263

Trevi Therapeutics Inc (TRVI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$2.77

Aprire:

$2.77

Volume 24 ore:

82,579

Relative Volume:

0.19

Capitalizzazione di mercato:

$215.99M

Reddito:

Utile/perdita netta:

$-29.07M

Rapporto P/E:

-8.8506

EPS:

-0.31

Flusso di cassa netto:

$-31.85M

1 W Prestazione:

-3.85%

1M Prestazione:

-17.91%

6M Prestazione:

+0.73%

1 anno Prestazione:

+113.18%

Intervallo 1D:

$2.73

$2.83

Intervallo di 1 settimana:

$2.67

$3.07

Portata 52W:

$0.97

$4.00

Trevi Therapeutics Inc Stock (TRVI) Company Profile

Nome

Trevi Therapeutics Inc

Settore

Healthcare (1195)

Industria

Biotechnology (683)

Telefono

203-304-2499

Indirizzo

195 CHURCH STREET, NEW HAVEN, CT

Dipendente

Cinguettio

@TreviThera

Prossima data di guadagno

2024-11-06

Ultimi documenti SEC

TRVI's Discussions on Twitter

Confronta TRVI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TRVI	2.74	215.99M	0	-29.07M	-31.85M	-0.31
VRTX	449.09	115.43B	10.63B	-479.80M	-1.35B	13.33
REGN	748.73	82.04B	13.85B	4.65B	3.32B	35.06
ARGX	587.28	35.30B	1.86B	-40.29M	-1.28B	-4.16
ALNY	247.66	32.04B	2.09B	-332.26M	16.06M	-4.14
BNTX	106.77	24.89B	3.30B	-501.07M	1.03B	11.54

Trevi Therapeutics Inc Stock (TRVI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-04-12	Iniziato	B. Riley Securities	Buy
2022-11-22	Iniziato	SVB Leerink	Outperform
2019-06-03	Iniziato	BMO Capital Markets	Outperform
2019-06-03	Iniziato	Needham	Buy
2019-06-03	Iniziato	SVB Leerink	Outperform
2019-06-03	Iniziato	Stifel	Buy

Mostra tutto

Trevi Therapeutics Inc Borsa (TRVI) Ultime notizie

07:30 AM

Trevi Therapeutics to Present Haduvio Development at Piper Sandler Healthcare Conference | TRVI Stock News - StockTitan

07:30 AM

Nov 16, 2024

Trevi Therapeutics to Participate in Upcoming April Events - GuruFocus.com

Nov 16, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Consensus Target Price from Brokerages - Defense World

Nov 16, 2024

Nov 14, 2024

Trevi Therapeutics to Present at the Emerging Growth Conference on February 22, 2023 - Quantisnow

Nov 14, 2024

Nov 13, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Receives $7.43 Average PT from Brokerages - MarketBeat

Nov 13, 2024

Nov 12, 2024

How Do Things Look For Trevi Therapeutics Inc (NASDAQ: TRVI) In The Short-Term? - Stocks Register

Nov 12, 2024

Trevi Therapeutics Announces Proposed Public Offering - Quantisnow

Nov 12, 2024

Trevi Therapeutics to Participate in Upcoming September Events - Quantisnow

Nov 12, 2024

Trevi Therapeutics to Present at H.C. Wainwright 24th Annual Global Investment Conference - Quantisnow

Nov 12, 2024

Trevi Therapeutics Provides Business Update Ahead of Upcoming Conferences - Quantisnow

Nov 12, 2024

Nov 11, 2024

FY2024 Earnings Forecast for TRVI Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024

Leerink Partnrs Has Negative Outlook of TRVI FY2024 Earnings - Defense World

Nov 11, 2024

Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates - Investing.com

Nov 08, 2024

Trevi Therapeutics' (TRVI) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 08, 2024

Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 08, 2024

Earnings call: Trevi Therapeutics reports Q3 2024 financials, clinical updates By Investing.com - Investing.com UK

Nov 08, 2024

Nov 07, 2024